• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma.第六届海德堡骨髓瘤研讨会会议报告：多发性骨髓瘤诊断与治疗的现状及进展
J Cancer Res Clin Oncol. 2017 Dec;143(12):2521-2526. doi: 10.1007/s00432-017-2463-x. Epub 2017 Jun 26.
2
Meeting report of the 5th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma.第五届海德堡骨髓瘤研讨会会议报告：多发性骨髓瘤诊断与治疗的现状及进展
J Cancer Res Clin Oncol. 2016 Jan;142(1):247-51. doi: 10.1007/s00432-015-1993-3. Epub 2015 Jun 12.
3
Meeting report of the 7th Heidelberg Myeloma Workshop: today and tomorrow.第七届海德堡骨髓瘤研讨会会议报告：今日与明日。
J Cancer Res Clin Oncol. 2019 Oct;145(10):2445-2455. doi: 10.1007/s00432-019-02998-w. Epub 2019 Aug 12.
4
Meeting report of the third Heidelberg myeloma workshop: current status and developments in diagnosis and therapy of multiple myeloma.
J Cancer Res Clin Oncol. 2012 Jan;138(1):173-8. doi: 10.1007/s00432-011-1071-4. Epub 2011 Sep 30.
5
Meeting report of the 4th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma.
J Cancer Res Clin Oncol. 2013 Nov;139(11):1807-11. doi: 10.1007/s00432-013-1468-3. Epub 2013 Jul 18.
6
Real-world outcomes of maintenance therapy post-autologous stem cell transplantation in newly diagnosed multiple myeloma.新诊断多发性骨髓瘤自体干细胞移植后维持治疗的真实世界疗效
BMC Cancer. 2025 Feb 5;25(1):204. doi: 10.1186/s12885-025-13518-0.
7
Early versus deferred treatment for early stage multiple myeloma.早期多发性骨髓瘤的早期治疗与延迟治疗
Cochrane Database Syst Rev. 2003;2003(1):CD004023. doi: 10.1002/14651858.CD004023.
8
Pharmacoeconomic evaluation of carfilzomib ixazomib for the treatment of relapsed and refractory multiple myeloma.卡非佐米与伊沙佐米治疗复发难治性多发性骨髓瘤的药物经济学评价
Future Sci OA. 2025 Dec;11(1):2514969. doi: 10.1080/20565623.2025.2514969. Epub 2025 Jun 18.
9
Systematic review and meta-analysis of the efficacy and safety of novel monoclonal antibodies for treatment of relapsed/refractory multiple myeloma.新型单克隆抗体治疗复发/难治性多发性骨髓瘤疗效与安全性的系统评价和荟萃分析
Oncotarget. 2017 May 16;8(20):34001-34017. doi: 10.18632/oncotarget.16987.
10
Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma.在恶性淋巴瘤或多发性骨髓瘤患者中，在使用粒细胞集落刺激因子的基础上加用普乐沙福用于造血干细胞动员以进行自体移植。
Cochrane Database Syst Rev. 2015 Oct 20;2015(10):CD010615. doi: 10.1002/14651858.CD010615.pub2.

第六届海德堡骨髓瘤研讨会会议报告：多发性骨髓瘤诊断与治疗的现状及进展

Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma.

作者信息

Merz Maximilian, Raab Marc S, Goldschmidt Hartmut, Hillengass Jens

机构信息

Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.

Max Eder Group Experimental Therapies for Hematologic Malignancies, German Cancer Research Center, Heidelberg, Germany.

出版信息

J Cancer Res Clin Oncol. 2017 Dec;143(12):2521-2526. doi: 10.1007/s00432-017-2463-x. Epub 2017 Jun 26.

DOI:10.1007/s00432-017-2463-x
PMID:28653099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11818947/
Abstract

PURPOSE

The 6th Heidelberg Myeloma Workshop was held on May 5th and 6th, 2017 in the lecture hall of the University Hospital Heidelberg.

METHODS AND RESULTS

Main topics of the meeting were (1) biology and genomics of multiple myeloma, (2) diagnostics and prognostic factors, (3) role of immunotherapy in multiple myeloma, as well as (4) therapy of multiple myeloma-drugs and treatment strategies.

CONCLUSION

The landscape for the treatment of newly diagnosed and relapsed disease has significantly changed since the last Heidelberg Myeloma Workshop in 2015. Updates on the current developments were presented at the meeting.

摘要

目的

第六届海德堡骨髓瘤研讨会于2017年5月5日至6日在海德堡大学医院的报告厅举行。

方法与结果

会议的主要议题包括：（1）多发性骨髓瘤的生物学与基因组学；（2）诊断与预后因素；（3）免疫疗法在多发性骨髓瘤中的作用；以及（4）多发性骨髓瘤的治疗——药物与治疗策略。

结论

自2015年上一届海德堡骨髓瘤研讨会以来，新诊断和复发疾病的治疗格局已发生显著变化。会议上介绍了当前进展的最新情况。